On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q1 2023 earnings per share (EPS) of -$1.05, up 43.55% year over year. Total Aileron Therapeutics earnings for the quarter were -$4.78 million. In the same quarter last year, Aileron Therapeutics's earnings per share (EPS) was -$1.86.
As of Q2 2023, Aileron Therapeutics's earnings has grown year over year. Aileron Therapeutics's earnings in the past year totalled -$23.69 million.
What was ALRN's revenue last quarter?
On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aileron Therapeutics's revenue was $0.00.
What was ALRN's revenue growth in the past year?
As of Q2 2023, Aileron Therapeutics's revenue has grown null year over year. Aileron Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.